204 related articles for article (PubMed ID: 30379686)
1. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
[TBL] [Abstract][Full Text] [Related]
2. Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy.
Wright ST; Hoy J; Mulhall B; Oʼconnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA
J Acquir Immune Defic Syndr; 2014 May; 66(1):55-64. PubMed ID: 24463783
[TBL] [Abstract][Full Text] [Related]
3. Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.
Quiros-Roldan E; Raffetti E; Castelli F; Focà E; Castelnuovo F; Di Pietro M; Gagliardini R; Gori A; Saracino A; Fornabaio C; Sighinolfi L; Di Filippo E; Maggiolo F; Donato F
J Antimicrob Chemother; 2016 Dec; 71(12):3519-3527. PubMed ID: 27543658
[TBL] [Abstract][Full Text] [Related]
4. Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment.
Chirouze C; Journot V; Le Moing V; Raffi F; Piroth L; Reigadas S; Cassuto JP; Chêne G; Leport C; Hoen B;
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):204-8. PubMed ID: 25590273
[TBL] [Abstract][Full Text] [Related]
5. Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients.
Falasca F; De Vito C; Mazzuti L; di Carlo D; Celani L; Fimiani C; dʼEttorre G; Mezzaroma I; Antonelli G; Turriziani O
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):423-428. PubMed ID: 30531307
[TBL] [Abstract][Full Text] [Related]
6. Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death.
Olson AD; Walker AS; Suthar AB; Sabin C; Bucher HC; Jarrin I; Moreno S; Perez-Hoyos S; Porter K; Ford D;
J Acquir Immune Defic Syndr; 2016 Sep; 73(1):100-8. PubMed ID: 27116045
[TBL] [Abstract][Full Text] [Related]
7. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
[TBL] [Abstract][Full Text] [Related]
8. Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana.
Kukoyi O; Renner L; Powell J; Barry O; Prin M; Kusah J; Cong X; Paintsil E
BMC Infect Dis; 2016 Feb; 16():58. PubMed ID: 26843068
[TBL] [Abstract][Full Text] [Related]
9. Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.
Xu Y; Chen X; Wijayabahu A; Zhou Z; Yu B; Spencer EC; Cook RL
Curr HIV Res; 2020; 18(3):143-153. PubMed ID: 32003696
[TBL] [Abstract][Full Text] [Related]
10. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
11. Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
Zaccarelli M; Lorenzini P; Tozzi V; Forbici F; Ceccherini-Silberstein F; Gori C; D'Arrigo R; Trotta MP; Narciso P; Perno CF; Antinori A;
Infection; 2009 Jun; 37(3):203-9. PubMed ID: 19274429
[TBL] [Abstract][Full Text] [Related]
12. Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir.
Sutter K; Lavender KJ; Messer RJ; Widera M; Williams K; Race B; Hasenkrug KJ; Dittmer U
Sci Rep; 2019 Dec; 9(1):18089. PubMed ID: 31792317
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis.
Atuhaire P; Hanley S; Yende-Zuma N; Aizire J; Stranix-Chibanda L; Makanani B; Milala B; Cassim H; Taha T; Fowler MG
PLoS One; 2019; 14(10):e0219415. PubMed ID: 31647806
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
[TBL] [Abstract][Full Text] [Related]
16. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
17. Predicting virological decay in patients starting combination antiretroviral therapy.
UK Collaborative HIV Cohort (UK CHIC) Writing Committee
AIDS; 2016 Jul; 30(11):1817-27. PubMed ID: 27124894
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D
AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320
[TBL] [Abstract][Full Text] [Related]
19. HIV viral exposure and mortality in a multicenter ambulatory HIV adult cohort, United States, 1995-2016.
Palella FJ; Armon C; Cole SR; Hart R; Tedaldi E; Novak R; Battalora L; Purinton S; Li J; Buchacz K;
Medicine (Baltimore); 2021 Jun; 100(25):e26285. PubMed ID: 34160393
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
